Cysteinyl leukotrienes are increased during acute lung injury in animals and humans. In this study, we determined the effect of leukotriene D 4 (LTD 4 ) on the function of Na,K-ATPase in alveolar epithelial cells and on alveolar fluid clearance in rat lungs. LTD 4 (1 ϫ 10 Ϫ7 M) increased Na,K-ATPase activity at 1 and 5 minutes by 14% (p Ͻ 0.05) and 31% (p Ͻ 0.001), respectively, in A549 alveolar epithelial cells. This was accompanied by recruitment of Na,K-ATPase ␣1 subunits from intracellular compartment(s) to the basolateral plasma membrane. LTD 4 -induced ␣1 Na,K-ATPase membrane translocation was blocked by the dual cysteinyl LT 1 (cysLT 1 )/ cysteinyl LT 2 (cysLT 2 ) receptor antagonist BAY-u9773, but not by the cysLT 1 antagonist MK571, implicating the cysLT 2 receptor. Expression of mRNA for cysLT 2 , but not cysLT 1 , was confirmed in A549 cells and rat alveolar type 2 cells by reverse transcriptase-polymerase chain reaction. Finally, compared with control, LTD 4 (1 ϫ 10 Ϫ11 M) increased alveolar fluid clearance by 41% (p Ͻ 0.001) in isolated, perfused rat lungs; this was also blocked by BAY-u9773 but not MK571. By activating alveolar epithelial Na,K-ATPase and increasing alveolar fluid reabsorption, cysteinyl leukotrienes may, in part, have a beneficial role in the acute respiratory distress syndrome.
The cysteinyl leukotrienes (LTs) LTC 4 , LTD 4 , and LTE 4 are potent proinflammatory lipid mediators derived from arachidonic acid (1, 2) . Studies in animals and humans have suggested a role for cysteinyl LTs in acute lung injury. Increased lung levels of LTC 4 and LTD 4 have been detected in various animal models of acute lung injury (3) (4) (5) (6) , and a cysteinyl LT receptor antagonist blocked endotoxin-induced pulmonary edema in pigs (6) . Elevated amounts of cysteinyl LTs have been also been detected in pulmonary edema and bronchoalveolar lavage fluid (7, 8) and in the urine (9) of patients with acute respiratory distress syndrome (ARDS). These findings, along with observations that LTC 4 and LTD 4 can increase microvascular permeability (10) (11) (12) , suggest that cysteinyl LTs play a role in the pathogenesis of noncardiogenic pulmonary edema.
A major determinant of the accumulation of pulmonary edema is the rate of alveolar fluid reabsorption across the alveo-lar epithelium (13) (14) (15) (16) . Alveolar fluid reabsorption occurs as a result of active Na ϩ transport across the epithelium, which creates an osmotic gradient, causing water to also move out of the alveolar space. Na ϩ enters alveolar epithelial cells via apical Na ϩ channels (17, 18) and is actively transported out of the cell by Na,K-ATPase, which is active in the basolateral membrane (19, 20) . The Na,K-ATPase is a ubiquitous heterodimeric transmembrane ion transporter that maintains Na ϩ and K ϩ gradients across cell membranes. It is composed of an ␣ subunit that hydrolyzes ATP and exchanges intracellular Na ϩ for extracellular K ϩ , and a ␤ subunit that controls enzyme assembly and insertion into the plasma membrane (21) .
The effect of cysteinyl LTs on the Na,K-ATPase in alveolar epithelial cells has not been studied. Indeed, whether epithelial cells in the lung or other tissues express either of the two cysteinyl LT receptors, cysLT 1 (22) or cysLT 2 (23) , is unknown. Epithelial expression of cysteinyl LT receptors seems likely, however, as it has been shown that LTD 4 triggers rapid signal transduction events in human epithelial cells (24) (25) (26) (27) .
In this study, we determined the effects of LTD 4 on the activity of Na,K-ATPase in cultured alveolar epithelial cells and on alveolar fluid clearance in the isolated, perfused rat lung. We report here, for the first time, that LTD 4 increases Na,K-ATPase activity and protein abundance in the basolateral membrane of A549 human alveolar epithelial cells. Using the selective cysLT 1 antagonist MK571 (22) and the dual cysLT 1 /cysLT 2 antagonist BAY-u9773 (23, 28), we provide evidence that LTD 4 exerts its effects through the cysLT 2 receptor in A549 cells. We also document the presence of mRNA for cysLT 2 , but not cysLT 1 , receptors in A549 cells and in rat alveolar type 2 (AT2) cells by reverse transcriptase-polymerase chain reaction. Finally, we show that LTD 4 increases lung liquid clearance, without changing permeability for small and large solutes, in the isolated, perfused rat lung. Together, these observations indicate that LTD 4 acts via the cysLT 2 receptor to upregulate Na,K-ATPase function in alveolar epithelial cells, and thereby increase lung liquid clearance. Some of the results of these studies have been previously reported in the form of an abstract (29) .
METHODS

Animals
Specific pathogen-free male Sprague-Dawley rats (Harlan Inc., Indianapolis, IN) were used for isolation of AT2 cells and for isolated, perfused lung experiments. Additional details are provided in the online supplement.
Culture of A549 Cells
A549 cells, a human lung adenocarcinoma-derived line with alveolar epithelial cell properties, were cultured in Dulbecco's modified Eagle medium containing 10% fetal calf serum. Additional details are provided in the online supplement.
Isolation and Culture of Rat AT2 Cells
Rat AT2 cells were isolated as previously described (30) . Additional details are provided in the online supplement.
Human Eosinophils
Eosinophils were purified from venous blood of human volunteers, as described previously (31) . Additional details are provided in the online supplement.
LTD 4 Stimulation and Cysteinyl LT Receptor Antagonists
In experiments involving cysteinyl LT stimulation, A549 cells were serum-starved for 24 hours before the addition of LTD 4 . Cells were stimulated with LTD 4 (Cascade Biochem Ltd., Berkshire, UK) at various concentrations or exposed to vehicle (dimethyl sulfoxide) alone for 1 to 5 minutes before the assessment of Na,K-ATPase activity, subcellular fractionation and Western blotting, or fixation for confocal microscopy. In selected experiments, A549 cells were incubated with the cysteinyl LT receptor antagonists MK571 (100 nM; Cayman Chemical, Ann Arbor, MI) or BAY-u9773 (3 M; Biomol, Plymouth Meeting, PA) for 15 minutes before and during exposure to LTD 4 .
Na,K-ATPase Activity Assay
The activity of Na,K-ATPase in A549 cells was determined as the ouabain-sensitive uptake of 86 Rb, as described (20) . Additional details are provided in the online supplement.
Basolateral Plasma Membrane Isolation
After stimulation with LTD 4 in the absence or presence of receptor antagonists, A549 cells were homogenized, and basolateral plasma membranes were isolated, as described (20) . Additional details are provided in the online supplement.
Immunoblotting of Na,K-ATPase
Immunoblotting was performed using a specific monoclonal antibody against the ␣1 subunit of Na,K-ATPase. Additional details are provided in the online supplement.
Confocal Immunofluorescence Microscopy
A549 cells stably transfected with a rat green fluorescent protein (GFP)-␣1 Na,K-ATPase plasmid (32) were cultured on glass coverslips and then stimulated with 1 ϫ 10 Ϫ7 M LTD 4 for 1 or 5 minutes, or exposed to vehicle alone. Cells were fixed, permeabilized, and immunostained with a rabbit monoclonal anti-GFP antibody (Molecular Probes, Eugene, OR), followed by Alexa-488-conjugated goat anti-rabbit IgG (Molecular Probes). Additional details are provided in the online supplement.
Reverse Transcriptase-Polymerase Chain Reaction
RNA was isolated from cultured cells and reverse transcribed. Polymerase chain reaction for the cysLT 1 and the cysLT 2 receptors was performed as detailed in the online supplement. 
Isolated, Perfused Rat Lung Model
Active Na ϩ transport and alveolar fluid reabsorption were measured in isolated, perfused, fluid-filled rat lungs, as described previously (15, 33) . Additional details are provided in the online supplement.
Statistical Analysis
Data are presented as means Ϯ SEM. Differences between group means were analyzed by the unpaired Student's t test or by one-way analysis of variance with Tukey's multiple comparison test, as appropriate (34) . Significance was determined at the p Ͻ 0.05 level. Statistical analyses were performed using GraphPad Prism (GraphPad Software, San Diego, CA).
RESULTS
Effect of LTD 4 on Alveolar Epithelial Na,K-ATPase Activity and ␣1 Protein Abundance in the Basolateral Membrane
First, we evaluated the effect of LTD 4 on Na,K-ATPase function in alveolar epithelial cells. A549 cells were incubated with LTD 4 at concentrations from 1 ϫ 10 Ϫ11 to 1 ϫ 10 Ϫ7 M, or vehicle alone, for 1 or 5 minutes at 37ЊC. As shown in Figure 1A , 1 ϫ 10 Ϫ7 M LTD 4 significantly increased Na,K-ATPase activity by 14% at 1 minute and by 31% at 5 minutes. Lower concentrations of LTD 4 did not significantly increase Na,K-ATPase activity (data not shown). At the same time that it increased Na,K-ATPase activity, LTD 4 (1 ϫ 10 Ϫ7 M) increased the amount of Na,K-ATPase ␣1 protein in the basolateral membrane of A549 cells at both 1 and 5 minutes ( Figure 1B) . Total ␣1 protein expression in whole-cell lysates from LTD 4 -stimulated and control cells was not different (data not shown), indicating that LTD 4 caused recruitment/translocation of Na,K-ATPase subunits from intracellular compartment(s) to the basolateral plasma membrane.
The effect of LTD 4 on the subcellular distribution of the Na, K-ATPase was further examined by immunofluorescence laserscanning confocal microscopy. A549 cells expressing GFP-tagged rat Na,K-ATPase ␣1 subunit (32) were incubated with LTD 4 (1 ϫ 10 Ϫ7 M), or vehicle control, for 1 or 5 minutes before fixation and immunostaining. Figure 2 shows that LTD 4 caused a timedependent increase in Na,K-ATPase ␣1 subunit abundance in the plasma membrane, which is best seen at the junctions between adjacent cells. These microscopic images thus corroborate the results obtained by immunoblotting of basolateral membrane fractions, as shown in Figure 1B . 
Role of the CysLT 2 Receptor
To examine whether the effects of LTD 4 on Na,K-ATPase were mediated by cysLT 1 or cysLT 2 receptors, we exposed A549 cells to LTD 4 in the absence and presence of MK571, a potent and selective cysLT 1 antagonist, and BAY-u9773, a dual cysLT 1 / cysLT 2 antagonist. As shown in Figure 3 , the increase in basolateral membrane Na,K-ATPase ␣1 protein stimulated by LTD 4 (1 ϫ 10 Ϫ7 M) was blocked by 3 M BAY-u9773, but not by 100 nM MK571. In a previous report (22) , this concentration of MK571 was sufficient to completely block LTD 4 -induced signaling in cells expressing human cysLT 1 and was 10-fold greater than the IC 50 for LTD 4 binding to cysLT 1 in radioligand-binding studies. LTD 4 -induced translocation of the Na,K-ATPase ␣1 subunit was also inhibited by pobilukast, another potent and selective cysLT 1 inhibitor (data not shown). Our data therefore strongly suggest that stimulation of Na,K-ATPase function by To assess further the role of the two cysteinyl LT receptors in alveolar epithelial cells, we used reverse transcriptasepolymerase chain reaction to determine the expression of mRNA for cysLT 1 and cysLT 2 in A549 and rat AT2 cells, as compared with human eosinophils, which are known to express both receptor isoforms (23, 35) . Figure 4 shows that both A549 and rat AT2 cells expressed mRNA for cysLT 2 , but neither expressed mRNA for cysLT 1 . Eosinophils expressed mRNA for both receptor isoforms, as expected. The finding that alveolar epithelial cells express cysLT 2 and not cysLT 1 receptors is consistent with the results of our experiments with inhibitors ( Figure 3) .
Effect of LTD 4 on Alveolar Fluid Clearance in the Isolated, Perfused Rat Lung
Finally, we examined the effect of LTD 4 on alveolar fluid clearance in the isolated, perfused rat lung model. LTD 4 at various concentrations, or vehicle alone, was added to the airspace instillate and to the perfusate of isolated, perfused rat lungs, and alveolar liquid clearance was determined after 1 hour. As shown in Figure induced increase in alveolar fluid clearance, whereas MK571 had no effect. These findings suggest that, like the effect of LTD 4 on Na,K-ATPase in A549 cells, the LTD 4 -induced increase in alveolar fluid clearance in rat lungs is mediated by cysLT 2 and not cysLT 1 .
DISCUSSION
This study is the first to examine the effects of a cysteinyl LT on Na,K-ATPase function in alveolar epithelial cells and on alveolar fluid clearance in rat lungs. We have found that LTD 4 rapidly (within 1 to 5 minutes) increases the activity of Na,KATPase in cultured A549 alveolar epithelial cells ( Figure 1A) . This observation provides a mechanistic basis for our additional finding that LTD 4 increases the rate of alveolar liquid clearance in isolated, perfused rat lungs ( Figure 5 ). These results were not expected because they reveal a potential protective role for cysteinyl LTs in relationship to the accumulation of pulmonary edema during acute lung injury.
At the same time that it increased Na,K-ATPase activity, LTD 4 increased the abundance of Na,K-ATPase ␣1 subunits at the basolateral membrane of alveolar epithelial cells. This was documented by immunoblotting of basolateral membrane fractions ( Figure 1B) and by confocal immunofluorescence microscopy (Figure 2 ), using an antibody directed at the Na,K-ATPase ␣1 subunit. There was no change in total ␣1 subunit protein detected in immunoblots of whole-cell lysates after LTD 4 stimulation, indicating that the increase in ␣1 subunits in the basolateral membrane resulted from redistribution of the pump from intracellular compartment(s). In previous studies, we have shown that isoproterenol (19) and dopamine (20, 36) rapidly activate Na,K-ATPase in alveolar epithelial cells by recruiting enzyme subunits from intracellular pools (late endosomes) to the basolateral membrane. Thus, LTD 4 , which like isoproterenol and dopamine, acts through G-protein-coupled receptors (22, 23) , upregulates alveolar epithelial Na,K-ATPase by a mechanism similar to that triggered by catecholamines.
The dual cysLT 1 /cysLT 2 receptor antagonist BAY-u9773, but not the highly selective cysLT 1 receptor antagonist MK571, blocked LTD 4 -induced translocation of the Na,K-ATPase ␣1 subunit to the basolateral membrane in A549 cells (Figure 3 ) and the increase in alveolar fluid clearance stimulated by LTD 4 in isolated, perfused rat lungs ( Figure 5 ). These results indicate that LTD 4 acts via the cysLT 2 rather than the cysLT 1 receptor in human and rat alveolar epithelial cells. The fact that A549 cells and rat AT2 cells both expressed mRNA for cysLT 2 and not cysLT 1 (Figure 4 ) further supports this conclusion. To our knowledge, this is the first documentation that cysteinyl LT receptors are present and functional in epithelial cells of any type. This finding is not without precedent, however, because cysteinyl LTs have previously been shown to affect epithelial cell function. For example, Leikauf and colleagues observed that cysteinyl LTs enhance the growth of human airway epithelial cells (37) , and more recently, LTD 4 has been shown to rapidly trigger Gprotein activation (24) , cytoskeletal reorganization (25) , calcium mobilization (26) , and activation of RhoA (27) Na in the isolated, perfused rat lung (data not shown), indicating that it did not affect alveolocapillary permeability at the concentration that increased alveolar fluid clearance in our model. Although the ability of cysteinyl LTs to promote microvascular leak has been established (10) (11) (12) , LTC 4 and LTD 4 did not increase lung microvascular permeability in a number of reports (38) (39) (40) . Our findings and those of these latter studies may reflect the possibility that LTD 4 affects permeability at only relatively high concentrations, while augmenting alveolar fluid reabsorption at lower levels. Also, it is important that we maintained pulmonary perfusion pressure at a constant low level in our model, thereby avoiding the pitfall of misinterpreting a change in transvascular fluid flux that would accompany a pulmonary vasopressor response to LTD 4 as a change in microvascular permeability.
LTD 4 increased alveolar fluid clearance in the isolated, perfused rat lung at a concentration (1 ϫ 10 Ϫ11 M) substantially lower than that that maximally increased Na,K-ATPase activity in A549 cells (1 ϫ 10 Ϫ7 M). This suggests the possibility that LTD 4 may affect alveolar fluid clearance in the rat by other mechanism(s), in addition to activation of Na,K-ATPase. Among these, another potentially important target of LTD 4 's action may be the alveolar epithelial apical Na ϩ channel. It is also possible that the difference in effective LTD 4 concentrations between our in vitro and isolated, perfused lung experiments might reflect alterations in cysLT 2 receptor expression, ligand affinity, or downstream signaling in A549 cells as a result of malignant transformation or due to in vitro culture conditions. Of note, the concentrations of LTD 4 detected in the pulmonary edema fluid of ARDS patients by Matthay and colleagues (7) were from 10 to 30 pM, in the same range as the concentration that we found to increase alveolar fluid clearance maximally in the isolated rat lung.
Our results suggest that the role of cysteinyl LTs in the pathophysiology of acute lung injury and ARDS is complex. Cysteinyl LTs may promote lung inflammation, microvascular permeability, and even fibroproliferation (41) , but at the same time, they may decrease pulmonary edema by increasing fluid clearance across the alveolar epithelium. In this regard, LTD 4 is similar to tumor necrosis factor-␣, another proinflammatory mediator in ARDS with the capacity to increase both vascular permeability (42) and alveolar fluid clearance (43, 44) . Furthermore, given the recent observation of Ware and Matthay (45) that higher pulmonary edema clearance rates correlated with a greater likelihood of recovery from ARDS, our findings suggest the possibility that cysteinyl LTs in the lung may actually have a salutary effect on patient outcome. Our results may also explain, in part, why ketoconazole, a LT synthesis inhibitor, failed to show benefit in a recent randomized, multicenter trial (46) . In summary, we have shown that the cysteinyl LTD 4 stimulates Na,K-ATPase function in alveolar epithelial cells and increases alveolar fluid reabsorption in the rat lung. LTD 4 activates the Na,K-ATPase by stimulating translocation/redistribution of the enzyme from intracellular compartment(s) to the basolateral membrane in a manner similar to catecholamines. LTD 4 exerts its effects on alveolar epithelial cells through the cysLT 2 receptor, whose expression we document here for the first time in epithelial cells of any origin. Our results suggest that cysteinyl LTs play a complex and, in part, beneficial role in the pathophysiology of acute lung injury and ARDS.
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